16 results
Vasculitis Management - ACR/VF 2021 Guidelines for Treatment & Management
 • Giant Cell Arteritis (GCA)
 •
Vasculitis Management - ACR ... Guidelines for Treatment ... • Giant Cell Arteritis ... #ACR2021 #Guidelines ... #algorithm #rheumatology
Giant Cell Arteritis (GCA) - Vasculitis Management Algorithm - ACR/VF 2021 Guidelines
 • Visual Symptoms/Loss or
Giant Cell Arteritis ... Vasculitis Management Algorithm ... - ACR/VF 2021 Guidelines ... Vasculitis #Management #Treatment ... #ACR2021 #Guidelines
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A
2017 ACC/AHA/HFSA ... Task Force on Clinical ... HeartFailure #Management #CHF ... ACCAHA2017 #cardiology #treatment ... #algorithm #sCHF
Short Stature - Differential Diagnosis Algorithm
Normal Variant, Normal Puberty Onset (BA = CA)
 • Familial Short
Differential Diagnosis Algorithm ... Panhypopituitarism Treatment ... Cystic Fibrosis, CHF ... endocrinology #causes ... #pediatrics
Septic Arthritis - Diagnosis and Management Summary
Clinical Exam: hot, swollen, pain with passive AND active ROM
Management Summary Clinical ... diagnosis Treatment ... 90% sensitive in pediatrics ... patient admitted for treatment ... results *** MH/CCF
Takayasu's Arteritis (TAK) - Vasculitis Management Algorithm - ACR/VF 2021 Guidelines
 • Active TAK not on
Takayasu's Arteritis ... Vasculitis Management Algorithm ... - ACR/VF 2021 Guidelines ... Vasculitis #Management #Treatment ... #ACR2021 #Guidelines
Drug Induced Lupus vs SLE
Drug Induced Lupus (DIL):
 • Epidemiology: -10% of all lupus cases, drug-dependent,
to 1:1 F:M • Clinical ... Constitutional symptoms, Arthritis ... Discontinuation of causal ... 40, F:M 9:1 • Clinical ... life-threatening • Treatment
Guillain-Barre Syndrome - Summary

Acute AIDP that presents with rapidly progressive flaccid weakness

Epidemiology:
 • 1-2 cases/100,000 per
Epidemiology: • 1-2 cases ... meningococcal, H1N1) Clinical ... complete paralysis of all ... Guillain-Barre Clinical ... Treatment: • Plasmapheresis
The algorithm below shows how pre-test probability could be combined with various criteria to determine which
short course of treatment ... provide empiric treatment ... empiric acyclovir to all ... HSV PCR would cause ... on the basis of CSF
Evaluation of suspected incomplete Kawasaki Disease

1. AHA consensus recommendations
2. Infants ≤6 months old on day ≥7
if they have no clinical ... purposes of this algorithm ... ≥2.5, coronary arteries ... echo is positive, treatment ... Diagnosis #Peds #Pediatrics